Innate and Adaptive Immune Response in Fabry Disease
Wladimir Mauhin(Sorbonne Université), Olivier Benvéniste(Inserm), K. Mariampillai(Inserm), Jean-Marc Ziza, Federico Mingozzi(Spark Therapeutics (United States)), Olivier Lidove(Groupe Hospitalier Diaconesses Croix Saint-Simon), Elisa Masat(Inserm)
Cited by 84
Related Papers
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
|Science Translational Medicine|2013|346
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
|Journal of Clinical Investigation|2013|232
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178